Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,360 | 899 | 99.3% |
| Education | $103.17 | 4 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,929 | 120 | $0 (2024) |
| ABBVIE INC. | $1,153 | 78 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,122 | 52 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,103 | 69 | $0 (2022) |
| Kowa Pharmaceuticals America, Inc. | $1,017 | 59 | $0 (2024) |
| Lilly USA, LLC | $977.81 | 62 | $0 (2024) |
| Amgen Inc. | $881.67 | 39 | $0 (2024) |
| ARBOR PHARMACEUTICALS, INC. | $796.62 | 80 | $0 (2021) |
| Avanir Pharmaceuticals, Inc. | $736.84 | 37 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $646.75 | 27 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,484 | 74 | Amgen Inc. ($337.96) |
| 2023 | $1,481 | 78 | Novo Nordisk Inc ($350.61) |
| 2022 | $1,285 | 79 | Kowa Pharmaceuticals America, Inc. ($274.91) |
| 2021 | $2,550 | 145 | Kowa Pharmaceuticals America, Inc. ($318.65) |
| 2020 | $1,855 | 108 | Allergan, Inc. ($348.79) |
| 2019 | $1,664 | 108 | ARBOR PHARMACEUTICALS, INC. ($270.61) |
| 2018 | $2,264 | 145 | AstraZeneca Pharmaceuticals LP ($227.53) |
| 2017 | $2,881 | 166 | Avanir Pharmaceuticals, Inc. ($477.48) |
All Payment Transactions
903 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.86 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $25.77 | General |
| Category: Respiratory | ||||||
| 12/03/2024 | Seqirus USA Inc | Flucelvax (Biological) | Food and Beverage | In-kind items and services | $29.56 | General |
| Category: Vaccines | ||||||
| 11/26/2024 | Kowa Pharmaceuticals America, Inc. | ZORYVE (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: DERMATOLOGY | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $28.61 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: PAIN | ||||||
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Diabetes | ||||||
| 10/15/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.90 | General |
| Category: Diabetes | ||||||
| 09/23/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Diabetes | ||||||
| 09/11/2024 | Amgen Inc. | KRYSTEXXA (Biological) | Food and Beverage | In-kind items and services | $2.74 | General |
| Category: Inflammation/Rare Disease | ||||||
| 09/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $5.01 | General |
| Category: Inflammation | ||||||
| 09/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Diabetes | ||||||
| 08/31/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.01 | General |
| Category: Diabetes | ||||||
| 08/29/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: Respiratory | ||||||
| 08/29/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $27.72 | General |
| 08/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.30 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $35.92 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 08/14/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: NEUROSCIENCE | ||||||
| 08/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $2.79 | General |
| Category: Inflammation | ||||||
| 07/25/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/23/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $30.96 | General |
| Category: Endocrinology | ||||||
| 07/17/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $8.90 | General |
| Category: NEUROSCIENCE | ||||||
| 07/15/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $33.23 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 546 | 791 | $87,330 | $65,738 |
| 2022 | 10 | 647 | 920 | $109,083 | $80,931 |
| 2021 | 10 | 754 | 1,008 | $106,504 | $80,255 |
| 2020 | 8 | 622 | 862 | $90,115 | $65,157 |
All Medicare Procedures & Services
38 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 207 | 423 | $47,483 | $31,730 | 66.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 131 | 131 | $21,313 | $20,423 | 95.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 58 | 67 | $10,921 | $7,235 | 66.2% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $1,520 | $1,415 | 93.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 22 | 22 | $1,440 | $1,412 | 98.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 42 | 42 | $1,429 | $1,178 | 82.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 23 | $1,505 | $1,128 | 75.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 12 | 18 | $1,309 | $909.54 | 69.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 23 | 23 | $408.02 | $306.02 | 75.0% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 13 | 22 | $2.64 | $2.07 | 78.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 204 | 399 | $44,755 | $29,146 | 65.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 155 | 155 | $25,285 | $24,587 | 97.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 169 | 210 | $33,233 | $22,767 | 68.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 20 | 22 | $1,639 | $1,094 | 66.7% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,054 | $1,035 | 98.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 15 | 19 | $1,243 | $978.74 | 78.7% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 12 | 42 | $745.08 | $559.90 | 75.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 16 | 16 | $508.86 | $438.96 | 86.3% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 29 | 30 | $617.88 | $323.85 | 52.4% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 11 | 11 | $1.32 | $1.08 | 81.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 198 | 277 | $37,875 | $25,430 | 67.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 206 | 368 | $35,886 | $24,509 | 68.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 160 | 160 | $23,236 | $23,047 | 99.2% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 34 | 35 | $2,128 | $2,128 | 100.0% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 15 | 15 | $1,925 | $1,322 | 68.7% |
About Dr. Lawrence Epstein, MD
Dr. Lawrence Epstein, MD is a Internal Medicine healthcare provider based in Mountain View, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093817728.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lawrence Epstein, MD has received a total of $15,464 in payments from pharmaceutical and medical device companies, with $1,484 received in 2024. These payments were reported across 903 transactions from 50 companies. The most common payment nature is "Food and Beverage" ($15,360).
As a Medicare-enrolled provider, Epstein has provided services to 2,569 Medicare beneficiaries, totaling 3,581 services with total Medicare billing of $292,081. Data is available for 4 years (2020–2023), covering 38 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Mountain View, CA
- Active Since 09/02/2006
- Last Updated 06/08/2015
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093817728
Products in Payments
- Livalo (Drug) $929.40
- XARELTO (Drug) $852.57
- Ozempic (Drug) $826.45
- VRAYLAR (Drug) $744.90
- NUEDEXTA (Drug) $673.12
- FARXIGA (Drug) $624.98
- JARDIANCE (Drug) $604.28
- Edarbi (Drug) $601.07
- Repatha (Biological) $491.72
- TRULICITY (Drug) $443.15
- Victoza (Drug) $440.38
- JANUVIA (Drug) $396.04
- UBRELVY (Drug) $364.91
- TRELEGY ELLIPTA (Drug) $324.42
- QULIPTA (Drug) $320.58
- Rybelsus (Drug) $295.35
- Vascepa (Drug) $293.99
- INVOKANA (Drug) $250.11
- NURTEC ODT (Drug) $242.45
- TOUJEO (Drug) $216.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Mountain View
Mr. Kenneth Peters, Md, MD
Internal Medicine — Payments: $111,214
Stephanie Wong, Md, MD
Internal Medicine — Payments: $23,168
Sanjeev Tummala, Md, MD
Internal Medicine — Payments: $15,128
Joseph Chao, M.d, M.D
Internal Medicine — Payments: $14,752
Dr. Suneetha Maddineni, M.d, M.D
Internal Medicine — Payments: $13,762
Edward Huang, Md, Mph, MD, MPH
Internal Medicine — Payments: $9,951